Expertise in
8
conditions

Jurgen O. Brunner

Krems An Der Donau, AT 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
8
conditions
Krems An Der Donau, AT 

Overview

Jurgen Brunner practices practicing medicine in Krems An Der Donau, Austria.

Brunner is highly rated in 8 conditions, according to our data. Their clinical expertise encompasses Scleroderma, Systemic Sclerosis (SSc), Juvenile Idiopathic Arthritis (JIA), and Osteomyelitis in Children.

They are actively involved in clinical research, co-authoring 51 peer reviewed articles and participating in 2 clinical trials.

Locations

Krems An Der Donau, Austria
Other Locations
Innsbruck, Austria
Bregenz, Austria

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3 Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients From 1 Year to <18 Years of Age With Juvenile Idiopathic Arthritis (JIA)
A Phase 3 Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients From 1 Year to <18 Years of Age With Juvenile Idiopathic Arthritis (JIA)
Enrollment Status: Recruiting
Publish Date: August 24, 2026
Intervention Type: Drug
Study Drug: Baricitnib
Study Phase: Phase 3
Open-Label, Randomized Study With a Tocilizumab Reference Arm to Evaluate Safety, Efficacy and Pharmacokinetics of Baricitinib in Children From 1 to Less Than 18 Years of Age With Systemic Juvenile Idiopathic Arthritis.
Open-Label, Randomized Study With a Tocilizumab Reference Arm to Evaluate Safety, Efficacy and Pharmacokinetics of Baricitinib in Children From 1 to Less Than 18 Years of Age With Systemic Juvenile Idiopathic Arthritis.
Enrollment Status: Active_not_recruiting
Publish Date: August 11, 2026
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
View 1 Less Clinical Trial

51 Total Publications

Interdisciplinary Clinical Practice Guidelines for patient-centred management of juvenile-onset systemic lupus erythematosus.
Interdisciplinary Clinical Practice Guidelines for patient-centred management of juvenile-onset systemic lupus erythematosus.
Journal: EULAR rheumatology open
Published: June 29, 2026

Frequently Asked Questions about Jurgen O. Brunner

Is Jurgen O. Brunner a top-rated expert for Scleroderma?

MediFind is an objective health platform that identifies experts based on real-world data. Jurgen O. Brunner is classified as an Distinguished expert for Scleroderma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jurgen O. Brunner participate in research or clinical trials?

Yes. Jurgen O. Brunner has published 51 articles and abstracts on conditions like Scleroderma. You can view a list of Jurgen O. Brunner's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Brunner's expertise for a condition
ConditionClose
    View All 31 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile